Nathan Rich
Stock Analyst at Goldman Sachs
(0.16)
# 3,654
Out of 4,667 analysts
89
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $16.50 | +27.31% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $177.33 | +10.53% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $18.68 | +60.60% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $8.32 | -3.85% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $21.35 | -18.03% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $295.50 | +30.29% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $13.41 | +4.44% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Neutral | $10 → $11 | $17.03 | -35.39% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $227.69 | -1.18% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $414.07 | +56.98% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $30 | $20.15 | +48.88% | 5 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $56.97 | +54.48% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $11.95 | +0.42% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $72.72 | +16.88% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $13.24 | -16.89% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $296.42 | +13.02% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $601.07 | -10.99% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $16.50
Upside: +27.31%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $177.33
Upside: +10.53%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $18.68
Upside: +60.60%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $8.32
Upside: -3.85%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $21.35
Upside: -18.03%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $295.50
Upside: +30.29%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $13.41
Upside: +4.44%
Teva Pharmaceutical
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $17.03
Upside: -35.39%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $227.69
Upside: -1.18%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $414.07
Upside: +56.98%
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $20.15
Upside: +48.88%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $56.97
Upside: +54.48%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $11.95
Upside: +0.42%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $72.72
Upside: +16.88%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $13.24
Upside: -16.89%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $296.42
Upside: +13.02%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $601.07
Upside: -10.99%